Adicet Bio, Inc.
ACET · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $23 | $28 | $23 | $23 |
| G&A Expenses | $5 | $4 | $7 | $7 |
| SG&A Expenses | $5 | $4 | $7 | $7 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $28 | $32 | $30 | $31 |
| Operating Income | -$28 | -$32 | -$30 | -$31 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1 | $1 | $2 | $2 |
| Pre-Tax Income | -$27 | -$31 | -$28 | -$29 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$27 | -$31 | -$28 | -$29 |
| % Margin | – | – | – | – |
| EPS | -0.29 | -0.34 | -0.31 | -0.32 |
| % Growth | 14.7% | -9.7% | 3.1% | – |
| EPS Diluted | -0.29 | -0.34 | -0.31 | -0.32 |
| Weighted Avg Shares Out | 91 | 91 | 91 | 88 |
| Weighted Avg Shares Out Dil | 91 | 91 | 91 | 88 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $2 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | -$25 | -$30 | -$27 | -$27 |
| % Margin | – | – | – | – |